ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹881 Cr | ₹92 Cr | ₹285 Cr | ₹269 Cr | ₹292 Cr |
What is the latest Contingent Liabilities ratio of ALKEM LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹881 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹285 Cr |
| Mar2022 | ₹269 Cr |
| Mar2021 | ₹292 Cr |
How is Contingent Liabilities of ALKEM LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹881 Cr | 860.69 | |
| Mar2024 | ₹92 Cr | -67.77 | |
| Mar2023 | ₹285 Cr | 5.93 | |
| Mar2022 | ₹269 Cr | -7.89 | |
| Mar2021 | ₹292 Cr | - | |
Compare Contingent Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹69,711.3 Cr | 0.6% | 3.8% | 9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 0.6% |
3.8% |
9.1% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses